The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing therapies for Acute Ischemic Stroke.

Total Raised

$5 M

Rounds

3

Links

Verticals

Biotechnology
Health Care
Neuroscience

Investment History

  1. Equity

    Sep 2025

    $3M

  2. Seed

    Dec 2023

    $2M

  3. Equity

    Nov 2018

    $1M

Team

Emmett-Phil Coriat

CEO

Ian Hitchcock

Chief Development Officer

Jina Swartz

Chief Medical Officer

Patricia Nasshorn

Chief Business Officer